Andrew T Turrisi
Overview
Explore the profile of Andrew T Turrisi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mauguen A, Le Pechoux C, Saunders M, Schild S, Turrisi A, Baumann M, et al.
J Clin Oncol
. 2012 Jul;
30(22):2788-97.
PMID: 22753901
Purpose: In lung cancer, randomized trials assessing hyperfractionated or accelerated radiotherapy seem to yield conflicting results regarding the effects on overall (OS) or progression-free survival (PFS). The Meta-Analysis of Radiotherapy...
2.
Johnson D, Rusch V, Turrisi A
J Natl Cancer Inst
. 2007 Mar;
99(6):415-8.
PMID: 17374824
No abstract available.
3.
Turrisi A, Crowley J, Albain K, Gaspar L, Gandara D
Semin Oncol
. 2005 Jul;
32(2 Suppl 3):S119-21.
PMID: 16015548
Over the past two decades, studies of the Southwest Oncology Group have consistently reported stable esophagitis rates despite changing scales with concurrent chest radiotherapy and cisplatin/etoposide regimens. Patient selection has...
4.
Turrisi A
Semin Oncol
. 2005 Jul;
32(2 Suppl 3):S6-8.
PMID: 16015529
Stage IIIa non-small cell lung cancer remains categorically a heterogeneous hodgepodge without clear prospective mandates for clinical care. Poor outcome ensues for patients with mediastinal node-positive cancer when treated with...
5.
Bogart J, Herndon 2nd J, Lyss A, Watson D, Miller A, Lee M, et al.
Int J Radiat Oncol Biol Phys
. 2004 May;
59(2):460-8.
PMID: 15145163
Purpose: To prospectively evaluate the feasibility of delivering 70 Gy once-daily thoracic radiotherapy (TRT), concurrent with chemotherapy, in the treatment of limited-stage small-cell lung cancer (L-SCLC). Materials And Methods: Eligible...
6.
Pfister D, Johnson D, Azzoli C, Sause W, Smith T, Baker Jr S, et al.
J Clin Oncol
. 2003 Dec;
22(2):330-53.
PMID: 14691125
No abstract available.
7.
Lyss A, Herndon 2nd J, Lynch Jr T, Turrisi A, Watson D, Grethlein S, et al.
Clin Lung Cancer
. 2003 Dec;
3(3):205-10.
PMID: 14662044
Chemotherapy for extensive-stage small-cell lung cancer (E-SCLC) produces high response rates and improved survival but few cures. We tested three new regimens for E-SCLC that might merit further investigation in...
8.
Mitas M, Hoover L, Silvestri G, Reed C, Green M, Turrisi A, et al.
J Mol Diagn
. 2003 Oct;
5(4):237-42.
PMID: 14573783
The clinical management of non-small cell lung cancer (NSCLC) would benefit greatly by a test that was able to detect small amounts of NSCLC in the peripheral blood. In this...
9.
10.
Sherman C, Turrisi A, Wallace M, Reed C
Curr Treat Options Oncol
. 2002 Oct;
3(6):475-85.
PMID: 12392637
Patients diagnosed with adenocarcinoma or squamous cell carcinoma of the esophagus should undergo computed tomography of the chest and abdomen and positron emission tomography to look for evidence of distant...